Aktiespot

Guided Therapeutics, Inc. Aktie

GTHP

Geschlossen
$0.22800.0000 (0.00%)
Chart wird geladen...
Guided Therapeutics, Inc. Logo

Guided Therapeutics, Inc.

Eröffnung0.2280
Hoch0.2280
Tief0.2280
Volumen500
P/EN/A
Marktkapitalisierung22.01M
52-Wochen-Hoch0.5400
52-Wochen-Tief0.1230
Durchschn. Volumen17.39k
DividendeN/A
Beta0.79
EPS-0.0400

Über Guided Therapeutics, Inc. Aktie

Guided Therapeutics, Inc., a medical technology company, researches, develops, tests, manufactures, sells, and distributes medical devices in the United States and internationally. It offers LuViva, an advanced cervical scan non-invasive cervical cancer detection device that provides less invasive and painless alternative to conventional tests for identifying, screening, and detecting cervical cancers and precancers. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is headquartered in Peachtree Corners, Georgia.

Unternehmensinformationen

Börse: OTC Markets OTCQB (OQB)
Sektor: Sundhed
Branche: Medicinsk udstyr
Adresse:
5835 Peachtree Corners East
30092 Peachtree Corners, United States
Telefon: + 770 242 8723

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: